The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 08, 2017
Filed:
Oct. 24, 2014
Applicant:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Inventors:
Ian Mangion, Cranford, NJ (US);
Cheng-yi Chen, Princeton, NJ (US);
Ingyu Jeon, Fanwood, NJ (US);
Yonggang Chen, Westfield, NJ (US);
Hongmei Li, Potomac, MD (US);
Hoa N. Nguyen, Corona, CA (US);
Peter E. Maligres, Fanwood, NJ (US);
Artis Klapars, Edison, NJ (US);
Ilia Zavialov, Furlong, PA (US);
Nobuyoshi Yasuda, Mountainside, NJ (US);
Assignee:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 498/04 (2006.01); C07D 403/04 (2006.01); C07C 215/50 (2006.01); C07F 5/02 (2006.01); C07C 213/02 (2006.01);
U.S. Cl.
CPC ...
C07D 498/04 (2013.01); C07C 213/02 (2013.01); C07C 215/50 (2013.01); C07D 403/04 (2013.01); C07F 5/025 (2013.01);
Abstract
The present invention is directed to a process for preparing Tetracyclic Heterocycle Compounds of formula (I): which are useful as HCV NS5A inhibitors. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).